https://www.wsj.com/articles/sticking-it-to-pharmawith-competition-1542674076
Sticking it to Pharma—With Competition
Nov. 19, 2018 7:34 p.m. ET
Did you hear that the Trump Administration has saved Americans $26 billion on prescription drugs? Probably not, and one person who seldom mentions it, oddly enough, is President Trump. A report from his own White House shows how faster approvals at the Food and Drug Administration are lowering prices.
The FDA has over 20 months of the Trump Administration approved an astounding 1,617 generic drugs, which are identical to branded versions but sold at commodity prices after patents expire.